It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study [RAW_REF_TEXT] Heinz Reichmann1 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Andrew Lees2 , [/RAW_REF_TEXT] [RAW_REF_TEXT] José-Francisco Rocha3 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Diogo Magalhães3,5 , [/RAW_REF_TEXT] [RAW_REF_TEXT] Patrício Soares-da-Silva 4,5,6 & [/RAW_REF_TEXT] [RAW_REF_TEXT] the OPTIPARK investigators [/RAW_REF_TEXT] Translational Neurodegeneration volume 9, Article number: 14 (2020) Cite this article [RAW_REF_TEXT] 131 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] [RAW_REF_TEXT] The original article was published in Translational Neurodegeneration 2020 9:9 [/RAW_REF_TEXT] Correction to: Correction to Fig. 2b Fig. 2 figure1 Global Impression of Change following 3 months treatment with opicapone 50 mg (a) investigator rated (CGI-C, n = 477, LOCF); (b) self-rated by the patient (PGI-C, n = 393) Full size image Rating scale outcomes Correction to UPDRS analyses (Table 2) Table 2 Rating scale assessments Full size table N numbers for UPDRS Part II were 475 at baseline and 389 at 3 months (Visit 4); results of the change from baseline analysis remain unchanged. Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study [RAW_REF_TEXT] Heinz Reichmann1 , Andrew Lees2 , José-Francisco Rocha3 , Diogo Magalhães3,5 , Patrício Soares-da-Silva 4,5,6 & the OPTIPARK investigators [/RAW_REF_TEXT] Translational Neurodegeneration volume 9, Article number: 14 (2020) Cite this article [RAW_REF_TEXT] 131 Accesses Metrics details The original article was published in Translational Neurodegeneration 2020 9:9
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Heinz Reichmann